ReviewLife (Basel, Switzerland)2025
Environmental Pollution from Pharmaceuticals.
Review in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Environmental Risk Assessment in Pharmaceutical Regulation: A Comparative Review of EMA, U.S. FDA and CDSCO Guidelines.Therapeutic innovation & regulatory science · 2026Review
- Chinese pharmacy students' knowledge, attitudes and practice about environmental risks of pharmaceuticals and their source control from the perspective of One Health.Frontiers in public health · 2026Article
- Drugs in the environment, viruses in the balance: a review of the untold nexus of pharmaceuticals and virology.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceuticals are invaluable allies in human and veterinary medicine, but their indiscriminate use can transform them into formidable pollutants-a threat that remains largely underestimated. The growth of the pharmaceutical market has increased the environmental presence of drugs, both as original compounds during production and as metabolites following administration. Particularly concerning is the presence of antibiotics in wastewater, which contributes to the development and spread of bacterial resistance. This review analyzes the primary causes of environmental pharmaceutical pollution and its impact on ecosystems. We describe the most significant results obtained from analyzing wastewater, primarily in Italy, but also in other European countries, and examine the official positions of environmental protection organizations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.